This fully automated device includes an image-guided robot for drawing blood from veins, a sample-handling module and a centrifuge-based blood analyzer.
Photo: Max Balter
New technology could speed hospital work, enhance health care
Rutgers researchers have created an automated blood drawing and testing device that provides rapid results, potentially improving the workflow in hospitals and other health-related institutions to allow health care practitioners to spend more time treating patients.
A study describing the fully automated device is published online in the journal TECHNOLOGY.
“This device represents the holy grail in blood testing technology,” said Martin L. Yarmush, senior author of the study and Paul & Mary Monroe Endowed Chair & Distinguished Professor in the Department of Biomedical Engineeringat Rutgers University–New Brunswick. “Integrating miniaturized robotic and microfluidic (lab-on-a-chip) systems, this technology combines the breadth and accuracy of traditional blood drawing and laboratory testing with the speed and convenience of point-of-care testing.”
Diagnostic blood testing is the most commonly performed clinical procedure in the world, and it influences most of the medical decisions made in hospitals and laboratories. But the success rate of manually drawing blood samples depends on clinicians’ skill and patient physiology, and nearly all test results come from centralized labs that handle large numbers of samples and use labor-intensive analytical techniques.
So, a Rutgers biomedical engineering research team created a device that includes an image-guided robot for drawing blood from veins, a sample-handling module and a centrifuge-based blood analyzer. Their device provides highly accurate results from a white blood cell test, using a blood-like fluid spiked with fluorescent microbeads. The testing used artificial arms with plastic tubes that served as blood vessels. The device could provide rapid test results at bedsides or in ambulances, emergency rooms, clinics and doctors’ offices.
“When designing the system, our focus was on creating a modular and expandable device,” said Max Balter, who led the study and holds a doctorate in biomedical engineering from Rutgers. “With our relatively simple chip design and analysis techniques, the device can be extended to incorporate a broader panel of tests in the future.”
Learn more: Rutgers Researchers Develop Automated Robotic Device For Faster Blood Testing
The Latest on: Blood testing
via Google News
The Latest on: Blood testing
- Newly funded research will use biomarkers from blood to understand how childhood shapes risks of Alzheimer's and other dementiason March 2, 2021 at 10:55 am
University of Minnesota research supported by $14.2 million in new funding from the National Institute on Aging.
- Parkinson's disease: Blood changes may occur years before diagnosison March 2, 2021 at 9:20 am
Although Parkinson's disease affects around 1%-2% of people over the age of 65, there is currently no cure. And by the time it is diagnosed—typically by identifying problems with movement, such as ...
- U.S. NIH halts trial testing COVID-19 blood plasmaon March 2, 2021 at 8:51 am
The U.S. National Institutes of Health (NIH) said on Tuesday it had halted a trial testing convalescent blood plasma in treatment of patients with mild to moderate COVID-19 symptoms.
- Blood drives scheduledon March 2, 2021 at 8:01 am
Tomah Health and Versiti Blood Center of Wisconsin will host a two-day blood drive from noon to 5 p.m. March 24-25 at Recreation Park, 1625 Butts Ave., Tomah. Donors are ...
- GRAIL Announces First Health System to Offer Galleri, Novel Multi-Cancer Early Detection Blood Teston March 2, 2021 at 5:34 am
GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured, today announced a partnership with leading health system Providence to advance the science and delivery ...
- Global Cord Blood Corporation Announces Receipt of Unsolicited Non-Binding Acquisition Proposalon March 2, 2021 at 4:50 am
Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage ...
- Blood tests can offer early indicator of severe Covid-19? Here's what study sayson March 2, 2021 at 4:41 am
As per a recent study, blood tests can help doctors predict whether a coronavirus patient requires care in the intensive care unit or requires ventilator support or is suffering from severe Covid-19 t ...
- Blood tests offer early indicator of severe COVID-19on February 26, 2021 at 9:51 am
When patients with COVID-19 arrive in emergency rooms, there are relatively few ways for doctors to predict which ones are more likely to become critically ill and require intensive care and which ...
- Blood tests offer early indicator of severe COVID-19, study sayson February 26, 2021 at 9:06 am
A new study reports that a series of biomarkers associated with white blood cell activation and obesity can predict severe outcomes in COVID-19 patients.
via Bing News
